Interleukin-17 (IL-17), which has a known role in the pathogenesis of psoriatic arthritis and RA, upregulates the expression of TRPV4 receptors and intensifies mechanical hyperalgesia [124,125]. Here, IL17A is linked to psoriatic arthritis.